Skip to content

Effect of Brahmi vati in Schizophrenia

Add-on effect of Brahmi vati capsules in the management of Schizophrenia-A Randomized Double-Blind Controlled Study - nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064540
Enrollment
100
Registered
2024-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F200- Paranoid schizophrenia

Interventions

None listed

Sponsors

Dr Dhanu S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects fulfilling DSM-V Diagnosis of Schizophrenia and Psychotic disorders. Receiving a stable dose of Antipsychotic agents for =4weeks. Symptom exacerbation had to extend =2weeks but =1 year .Participants will be enrolled only if their PANSS total score is =60. Patients who are on anti-psychotics as well as anticholinergic medications.

Exclusion criteria

Exclusion criteria: Pregnancy or breastfeeding. Organic psychotic disorders. Patients who have received Electro-convulsive therapy. Known case of BPH. patients whose serum creatinine is greater than 1.5mg/dl. Already diagnosed co-morbidities like unsatisfactory control of Diabetes mellitus FBS greater than 125mg/dl or PPBS greater than 180mg/dl or HbA1C greater than 7 Hypertension greater than 140/90mmHg.

Design outcomes

Primary

MeasureTime frame
PANSS(Positive And negative syndrome scale)Timepoint: Baseline, 15th,30th,45th and 60th day.

Secondary

MeasureTime frame
MoCA (Montreal cognitive assessment) PSQI (Pitts Burg sleep quality index) CDSS (Calgary depression scale for schizophrenia) WHOQOL-BREF (Quality of life) CGI (Clinical Global Impression Scale) UKU side effect scale[24]Timepoint: Baseline, 15th,30th,45th and 60th day.

Countries

India

Contacts

Public ContactDr Basavaraj R Tubaki

KAHERs Shri BMK Ayurveda Mahavidyalaya Shahapur Belagavi

ayurbasavaraj@gmail.com9448634660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026